Nashville, Tennessee — According to state and local economic development sources August Bioservices plans to invest $64,700,000.00 to build out new space in Nashville. The company plans to occupy the new space at 1845 Elm Hill Pike in Nashville, on or about November 1, 2021. According to the company website August Bioservices is a team of highly experienced life science experts providing rigorous research, pharmaceutical development, and early-phase clinical manufacturing services to clients in the pharmaceutical and biotechnology space. We pride ourselves on our abilities, integrity, and persistence in the face of challenge, and will exert maximal effort and ingenuity to achieve your goals. We also specialize in nanosuspensions and microfluidics for Phase I and Phase II clinical trial production. Benefit from our small to medium-scale cGMP non-sterile bulk liquid and semi-solid manufacturing services and our aseptic manufacturing with sterile filling processes. Your next project or drug discovery campaign will flourish with August Bio’s personalized service and strategic solutions.

To learn more about August Bioservices, visit http://www.augustbio.com/

Company Contact:
Jenn Adams, Chief Executive Officer
https://www.linkedin.com/in/jenn-adams1234/
615-515-5400

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved